Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
As these pivotal challenges are incrementally addressed, LONP1 is poised to become a cornerstone therapeutic target for mitochondrial dysfunction-related diseases, potentially redefining existing treatment paradigms
Mutated GST sequences were subcloned into pET-15b, pET-24d, pGEX 4T-1, and pCMV-2B expression vectors, and the mutated constructs were confirmed by DNA sequencing
The pharmacokinetic parameters, including substrate affinity for P-glycoprotein (P-gp) and inhibitory potential against cytochrome P450 (CYP450) enzyme isoforms, were predicted using support-vector-machine-based binary classification models embedded within the SwissADME framework
Shots may help reduce or prevent this damage
It has been working great
US$ 23.06
US$ 22.33
US$ 24.87
US$ 26.48
US$ 27.59
